Top Pharmaceuticals stocks in Australia
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$134.25bn | 35.12 | 1.38% |
NEUNeuren Pharmaceuticals | AU$2.68bn | 17.06 | n/a |
SIGSigma Healthcare | AU$1.94bn | 291.27 | 0.8% |
CUVClinuvel Pharmaceuticals | AU$771.46m | 25.53 | 0.32% |
MYXMayne Pharma | AU$517.54m | n/a | n/a |
BOTBotanix Pharmaceuticals | AU$440.94m | n/a | n/a |
PBPProbiotec | AU$237.46m | 26.12 | 2.4% |
VLSVita Life Sciences | AU$121.26m | 12.96 | 4.19% |
RCERecce Pharmaceuticals | AU$121.20m | n/a | n/a |
NXSNext Science | AU$91.88m | n/a | n/a |
PAAPharmaust | AU$69.20m | n/a | n/a |
IHLIncannex Healthcare | AU$65.07m | n/a | n/a |
VITVitura Health | AU$63.35m | 6.68 | 9.09% |
BIOBiome Australia | AU$61.48m | n/a | n/a |
SPLStarpharma Holdings | AU$45.30m | n/a | n/a |
LGPLittle Green Pharma | AU$37.51m | n/a | n/a |
MVPMedical Developments International | AU$37.11m | n/a | n/a |
NOXNoxopharm | AU$21.04m | n/a | n/a |
IMCImmuron | AU$20.50m | n/a | n/a |
ACRAcrux | AU$18.54m | n/a | n/a |